South Korea: Lunit files registration statement with Korean Exchange for IPO

Lunit, a leading provider of AI solutions for cancer, has filed a registration statement with the Korean Exchange for an IPO of its common stock. The company intends to list its common stock on the KOSDAQ market. NH Investment & Securities will act as bookrunner. A total of 1,124,300 shares will be offered in the…

You must be a HMI Subscriber to view this content.

Subscribe Now »